Chemomab Therapeutics (NasdaqCM:CMMB) FY Conference Transcript

Chemomab Therapeutics (NasdaqCM:CMMB) FY Conference February 26, 2026 08:00 AM ET Speaker1Good morning, everyone, and welcome back to day two of Oppenheimer's 36th Annual Healthcare Conference. I'm Jeff Jones, one of the biotech analysts on the team here, and I am delighted to welcome Adi Mor, CEO of Chemomab Therapeutics, to give us an update on their story. Adi, I will hand it off to you.Speaker0Thank you very much, Jeff. My pleasure to be here today and presenting Chemomab at the Oppenheimer Conference. ...